Financials

Acadia Healthcare Company Inc. financials

ACHC Health Care Providers and Services

Acadia Healthcare Company Inc. is a publicly traded provider of specialty behavioral health services in the United States, founded in 1987 and headquartered in Franklin, Tennessee, United States. The company operates over 180 facilities that deliver inpatient psychiatric care, residential addiction treatment, and outpatient mental health services. Under Interim CEO Kevin Truitt, Acadia emphasizes integrated treatment models and digital health innovations. This diversified approach positions the company to effectively navigate regulatory pressures and capitalize on growth opportunities in the evolving healthcare market.

Snapshot

Acadia Healthcare Company Inc. reported $3.31B in revenue in fiscal 2025, up 5.0% year over year, with an operating margin of -28.2%.

Revenue (FY2025)
$3.31B
YoY growth
+5.0%
Operating margin
-28.2%
Direction
Expanding

Financial statements

In thousands, USD
FY 2025FY 2024FY 2023FY 2022
Total Revenues3,312,7703,153,9602,928,7402,610,400
Gross Profit3,312,7703,153,9602,928,7402,610,400
Selling, General & Administrative Expenses2,064,2001,928,5901,794,9001,596,910
Depreciation & Amortization Expenses189,249149,595132,349117,769
Other Operating Expenses1,993,840617,530960,895473,269
Operating Profit(934,523)458,24740,599422,452
Interest Expense(138,864)(116,368)(82,125)(69,760)
Non-Operating Income7,446—16,16621,451
Total Non-Operating Income(131,418)(116,368)(65,959)(48,309)
Income Before Provision for Income Taxes(1,065,940)341,879(25,360)374,143
Provision for Income Taxes25,98277,395(9,699)94,110
Consolidated Net Income(1,091,920)264,484(15,661)280,033
Net Income Attributable to Minority Interests and Other10,8498,8726,0066,894
Net Income Attributable to Common Shareholders(1,102,770)255,612(21,667)273,139
Basic EPS-12.162.79-0.243.05
Diluted EPS-12.162.78-0.242.98
Basic Weighted Average Shares Outstanding90,70591,62190,94989,680
Diluted Weighted Average Shares Outstanding90,70592,05990,94991,555
Shares Outstanding90,45291,77591,26489,914
In thousands, USD
FY 2025FY 2024FY 2023FY 2022
Cash and Cash Equivalents133,24276,305100,07397,649
Total Cash and Cash Equivalents133,24276,305100,07397,649
Accounts Receivable440,604365,339361,451322,439
Total Trade Receivables440,604365,339361,451322,439
Other Current Assets240,293135,848134,47686,037
Total Current Assets814,139577,492596,000506,125
Net Property, Plant & Equipment3,245,2202,971,5602,384,3902,087,280
Net Intangible Assets96,67270,00373,27876,041
Goodwill——2,225,9602,222,810
Other Long-Term Assets75,07873,00779,21195,647
Total Assets5,527,4505,956,9205,358,8404,987,900
Accounts Payable150,403232,704156,132104,723
Accrued Expenses325,193242,937674,162235,890
Current Portion of Long-Term Debt28,43876,81629,21921,250
Current Portion of Leases21,16025,46226,26826,463
Total Current Liabilities525,194577,919885,781388,326
Long-Term Debt2,471,5301,880,0901,342,5501,364,540
Leases121,961101,828100,808116,429
Other Long-Term Liabilities268,212206,244142,044217,621
Total Long-Term Liabilities2,861,7002,188,1701,585,4001,698,590
Total Liabilities3,386,9002,766,0802,471,1802,086,920
Common Stock905918913899
Additional Paid-in Capital2,713,9002,685,4602,649,3402,658,440
Retained Earnings(765,841)387,333131,721153,388
Total Common Shareholders' Equity1,948,9603,073,7202,781,9702,812,730
Minority Interests and Other191,592117,116105,68688,257
Total Shareholders' Equity2,140,5503,190,8302,887,6602,900,980
Total Liabilities and Shareholders' Equity5,527,4505,956,9205,358,8404,987,900
In thousands, USD
FY 2025FY 2024FY 2023FY 2022
Net Income(1,091,920)264,484(15,661)280,033
Depreciation & Amortization189,249149,595132,349117,769
Share-Based Compensation Expense31,70837,11332,28929,635
Other Adjustments1,011,53084,386306,73022,486
Changes in Trade Receivables(75,024)(2,329)(39,012)(41,978)
Changes in Accounts Payable14,882(420,893)17,4045,174
Changes in Accrued Expenses26,67812,11516,5326,804
Changes in Other Operating Activities24,7975,22211,709(39,354)
Cash from Operating Activities131,898129,693462,340380,569
Capital Expenditure(571,807)(690,385)(424,133)(296,149)
Proceeds from Sale of Property, Plant & Equipment23,84810,43529,4227,074
Payments for Business Acquisitions(8,165)(53,550)(349)(9,507)
Other Investing Activities(90)(2,979)(2,159)(7,248)
Cash from Investing Activities(556,214)(736,479)(397,219)(305,830)
Issuance of Short-Term Debt1,069,000305,00040,000—
Repayments of Short-Term Debt(1,035,000)(15,000)(35,000)(95,000)
Net Issuance / (Repayments) of Short-Term Debt34,000290,0005,000(95,000)
Issuance of Long-Term Debt1,200,000350,000——
Repayments of Long-Term Debt(683,044)(56,331)(21,250)(18,594)
Net Issuance / (Repayments) of Long-Term Debt516,956293,669(21,250)(18,594)
Repurchases of Common Shares(54,260)(1,341)(44,335)(6,179)
Net Issuance / (Repurchases) of Common Shares(54,260)(1,341)(44,335)(6,179)
Other Financing Activities(15,443)690(2,112)8,870
Cash from Financing Activities481,253583,018(62,697)(110,903)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash56,937(23,768)2,424(36,164)

Key metrics

$1.28B
Market Cap
-1.17x
P/E
0.39x
P/S
-5.35x
EV/EBITDA
-41.0%
Return on Equity
-18.4%
Return on Invested Capital
1.55x
Current Ratio
-13.3%
Free Cash Flow Margin

Quarterly trend

QuarterRevenueYoY growthOperating marginOperating income
Q1 2026$829M+7.6%5.8%$48M
Q4 2025$821M+6.1%-137.7%$-1.13B
Q3 2025$852M+4.4%9.0%$77M
Q2 2025$869M+9.2%8.8%$76M
Q1 2025$771M—5.7%$44M
Q4 2024$774M—8.8%$68M
Q3 2024$816M—15.8%$128M
Q2 2024$796M—17.0%$136M

Margins

100.0%
Gross margin
-28.2%
Operating margin
-33.0%
Net margin
SourceCompany financial filings (income statement, balance sheet, cash flow) Last updated

More on Acadia Healthcare Company Inc.

CompanyAcadia Healthcare Company Inc. overview FacetLeadership & people FacetLeadership

See how VectorShift works for your firm

Request Demo